Semiparametric Allocation of Subjects to Cohort Strata AM Walker, M Russo, MC Schneeweiss, RJ Glynn Epidemiology 35 (2), 213-217, 2024 | | 2024 |
Stratified analysis in comparative effectiveness studies that emulate randomized trials PT Htoo, RJ Glynn, S Wang, JM Paik, S Schneeweiss, AM Walker, ... Pharmacoepidemiology and Drug Safety 33 (1), e5716, 2024 | 3 | 2024 |
Rotator cuff outcomes and mental health indices: Correlation or causation? MT Sabo, A Walker, G Elmi Assadzadeh, KA Hildebrand Shoulder & Elbow 15 (4_suppl), 108-118, 2023 | | 2023 |
Association of ultra-widefield fluorescein angiography–identified retinal nonperfusion and the risk of diabetic retinopathy worsening over time PS Silva, DM Marcus, D Liu, LP Aiello, A Antoszyk, M Elman, S Friedman, ... JAMA ophthalmology 140 (10), 936-945, 2022 | 33 | 2022 |
Association of predominantly peripheral lesions on ultra-widefield imaging and the risk of diabetic retinopathy worsening over time DM Marcus, PS Silva, D Liu, LP Aiello, A Antoszyk, M Elman, S Friedman, ... JAMA ophthalmology 140 (10), 946-954, 2022 | 44 | 2022 |
The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin–clavulanate in US Veterans M DerSarkissian, Y Young‐Xu, MS Duh, RH Bhak, N Palmetto, ... Pharmacoepidemiology and Drug Safety 31 (8), 840-850, 2022 | | 2022 |
An evaluation of the effect of the oxycontin reformulation on unintentional fatal and nonfatal overdose DC Beachler, K Hall, R Garg, G Banerjee, L Li, L Boulanger, H Yuce, ... The Clinical Journal of Pain 38 (6), 396-404, 2022 | 5 | 2022 |
Online chat and chatbots to enhance mature student engagement in higher education N Abbas, J Whitfield, E Atwell, H Bowman, T Pickard, A Walker International Journal of Lifelong Education 41 (3), 308-326, 2022 | 58 | 2022 |
Formic: Foraging via multiagent rl with implicit communication S Shaw, E Wenzel, A Walker, G Sartoretti IEEE Robotics and Automation Letters 7 (2), 4877-4884, 2022 | 8 | 2022 |
POSA68 Cost Minimization Analysis of Fixed-Dose Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Versus Open Triple Therapy for Moderate-to-Very Severe COPD in … E de Nigris, U Holmgren, C Treharne, N Brighton, A Walker, J Haughney Value in Health 25 (1), S46, 2022 | 1 | 2022 |
POSA67 Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Versus Dual Therapies in Moderate-to-Very Severe COPD: United Kingdom Analysis … E de Nigris, C Treharne, N Brighton, U Holmgren, M Jenkins, A Walker, ... Value in Health 25 (1), S46, 2022 | 1 | 2022 |
Lapses in care among patients assigned to ranibizumab for proliferative diabetic retinopathy: a post hoc analysis of a randomized clinical trial MG Maguire, D Liu, SB Bressler, SM Friedman, M Melia, CR Stockdale, ... JAMA ophthalmology 139 (12), 1266-1273, 2021 | 19 | 2021 |
S104 Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate versus dual therapies in moderate-to-very severe COPD in the United Kingdom … E de Nigris, U Holmgren, C Treharne, N Brighton, A Walker, J Haughney Thorax 76 (Suppl 2), A66-A67, 2021 | 1 | 2021 |
Lifetime Benefits for Budesonide/Glycopyrrolate/Formoterol Fumarate versus Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist and Inhaled Corticosteroid/Long … E De Nigris, C Treharne, N Brighton, U Holmgren, A Walker, J Haughney TP40. TP040 COPD CLINICAL TRIALS AND THERAPIES, A2248-A2248, 2021 | 1 | 2021 |
Projections of healthcare resource utilization and costs related to exacerbations for budesonide/glycopyrrolate/formoterol fumarate versus dual long-acting muscarinic … E De Nigris, C Treharne, N Brighton, U Holmgren, A Walker, J Haughney TP40. TP040 COPD CLINICAL TRIALS AND THERAPIES, A2249-A2249, 2021 | 1 | 2021 |
Vaccine safety: looking forward and back AM Walker, WA Orenstein BMJ Global Health 6 (Suppl 2), 2021 | 2 | 2021 |
Configuration of the extra-renal venous system in relation to the left renal vein: A cadaveric study and new proposed classification A Walker, N Slim, M Nicholson, C Brassett The Surgeon 18 (6), 349-353, 2020 | 2 | 2020 |
The acute effects of azithromycin use, as compared with amoxicillin-clavulanate, on cardiovascular mortality in United States veterans M DerSarkissian, MS Duh, R Bhak, N Palmetto, Y Young-Xu, E Mortensen, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 579-579, 2020 | | 2020 |
Complementary hypotheses in safety surveillance AM Walker Sequential Analysis 39 (3), 417-430, 2020 | | 2020 |
Using quality-improvement framework and methodologies to spread fasting improvement change in Royal Hospital for Children, Glasgow S Ong, A Steinhart, N Boslem, G White, A Walker ANAESTHESIA 75, 97-97, 2020 | | 2020 |